arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

MYOMO, INC.

MYO
$1.42 ▲ +0.10 (+7.58%) at close
Healthcare ·Orthopedic, Prosthetic & Surgical Appliances & Supplies ·USOrthopedic, Prosthetic & Surgical Appliances & Supplies
42 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
17
Health
Poor
Bearish
auto_awesome

Analytical Summary

MYOMO, INC. faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $60.0M
Dividend Yield
Revenue Growth 2.9%
Op. Margin -31.2%
ROIC -16.9%
FCF / Share $-0.06
Trailing P/E
Price / Book 6.1x
FCF Yield
Debt / Equity 1.21
info Valuation on last close. End-of-day price, Aug 7, 2026.

42-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$10.11M
↑ +2.9%
Net Income Profit after all expenses
$-3.01M
↑ +13.2%
Operating Margin Operating profit as % of sales
-31.2%
↓ -27.8% 7th
FCF / Share Free cash flow per share
$-0.06
↑ +26.0%
Long-Term Debt Long-term obligations
$10.93M
↓ -2.6%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability
6
Returns
6
Financial Health
21
Cash Quality
68

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 11 years · 42 quarters